HIGH GRADE NEUROENDOCRINE CANCERS

Clinical trials for HIGH GRADE NEUROENDOCRINE CANCERS explained in plain language.

Never miss a new study

Get alerted when new HIGH GRADE NEUROENDOCRINE CANCERS trials appear

Sign up with your email to follow new studies for HIGH GRADE NEUROENDOCRINE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo tested to fight back against Tough-to-Treat cancers

Disease control Ongoing

This study is testing whether combining two drugs, lurbinectedin and berzosertib, can shrink tumors in people with aggressive small cell lung cancer or high-grade neuroendocrine cancers that have returned after prior treatment. The first part of the trial aims to find the safest …

Matched conditions: HIGH GRADE NEUROENDOCRINE CANCERS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

HIGH GRADE NEUROENDOCRINE CANCERS

Get alerted when new HIGH GRADE NEUROENDOCRINE CANCERS trials appear

New drug duo tested to fight back against Tough-to-Treat cancers